| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/SREP04160 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/srep04160 |
| P932 | PMC publication ID | 3932448 |
| P698 | PubMed publication ID | 24561821 |
| P5875 | ResearchGate publication ID | 260374843 |
| P50 | author | Abraham Alahmad | Q43092495 |
| P2093 | author name string | Sean P Palecek | |
| Eric V Shusta | |||
| Ethan S Lippmann | |||
| Samira M Azarin | |||
| P2860 | cites work | The blood-brain barrier: bottleneck in brain drug development | Q22336985 |
| Pericytes are required for blood-brain barrier integrity during embryogenesis | Q24627396 | ||
| A perivascular origin for mesenchymal stem cells in multiple human organs | Q28131808 | ||
| A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A | Q28285192 | ||
| Essential regulation of CNS angiogenesis by the orphan G protein-coupled receptor GPR124. | Q28507603 | ||
| Wnt/beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis | Q28594356 | ||
| The blood-brain barrier in health and chronic neurodegenerative disorders | Q29616411 | ||
| Central nervous system pericytes in health and disease | Q33609398 | ||
| The mouse blood-brain barrier transcriptome: a new resource for understanding the development and function of brain endothelial cells | Q33741896 | ||
| Revealing a core signaling regulatory mechanism for pluripotent stem cell survival and self-renewal by small molecules | Q33929545 | ||
| Modelling of the blood-brain barrier in drug discovery and development. | Q34005458 | ||
| Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study | Q34032708 | ||
| Constitutive androstane receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier | Q34128009 | ||
| SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier | Q34206194 | ||
| Aryl hydrocarbon receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier | Q34502705 | ||
| 17-β-Estradiol: a powerful modulator of blood-brain barrier BCRP activity | Q34502756 | ||
| Angiotensin II controls occludin function and is required for blood brain barrier maintenance: relevance to multiple sclerosis | Q34666702 | ||
| Assigning the positional identity of spinal motor neurons: rostrocaudal patterning of Hox-c expression by FGFs, Gdf11, and retinoids. | Q52126162 | ||
| Retinoid signalling acts during the gastrula stages to promote primary neurogenesis. | Q52164327 | ||
| mRNA expression levels of tight junction protein genes in mouse brain capillary endothelial cells highly purified by magnetic cell sorting. | Q53519195 | ||
| Pericytes from Brain Microvessels Strengthen the Barrier Integrity in Primary Cultures of Rat Brain Endothelial Cells | Q57283471 | ||
| A sonic hedgehog-independent, retinoid-activated pathway of neurogenesis in the ventral spinal cord | Q77983175 | ||
| Establishment of primary cultures of human brain microvascular endothelial cells to provide an in vitro cellular model of the blood-brain barrier | Q35029148 | ||
| Blood-brain barrier modeling with co-cultured neural progenitor cell-derived astrocytes and neurons | Q35341255 | ||
| Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology. | Q36166111 | ||
| Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells | Q36306295 | ||
| 1α,25-Dihydroxyvitamin D3-liganded vitamin D receptor increases expression and transport activity of P-glycoprotein in isolated rat brain capillaries and human and rat brain microvessel endothelial cells | Q36512766 | ||
| Modeling the blood-brain barrier using stem cell sources | Q36588683 | ||
| Establishment of a simplified in vitro porcine blood-brain barrier model with high transendothelial electrical resistance | Q36959343 | ||
| Self-organized vascular networks from human pluripotent stem cells in a synthetic matrix | Q37068457 | ||
| Differentiating embryonic neural progenitor cells induce blood-brain barrier properties | Q37131752 | ||
| Retinoic acid induces blood-brain barrier development. | Q39205654 | ||
| Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier | Q40015379 | ||
| Blood-brain barrier-specific properties of a human adult brain endothelial cell line | Q40377619 | ||
| Modulation of P-glycoprotein activity by glial factors and retinoic acid in an immortalized rat brain microvessel endothelial cell line | Q41076019 | ||
| Induction of blood-brain barrier differentiation in a rat brain-derived endothelial cell line | Q41301625 | ||
| An early role for WNT signaling in specifying neural patterns of Cdx and Hox gene expression and motor neuron subtype identity | Q41564030 | ||
| A cell culture model of the blood-brain barrier | Q42006322 | ||
| Gene expression in human neural stem cells: effects of leukemia inhibitory factor. | Q42443012 | ||
| Relationship between permeability status of the blood-brain barrier and in vitro permeability coefficient of a drug | Q42496777 | ||
| Human blood-derived macrophages enhance barrier function of cultured primary bovine and human brain capillary endothelial cells | Q44493503 | ||
| A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes | Q45351723 | ||
| Cerebrovascular permeability coefficients to sodium, potassium, and chloride | Q45876503 | ||
| Closing the gap between the in-vivo and in-vitro blood-brain barrier tightness. | Q45980701 | ||
| Murine brain capillary endothelial cells exhibit improved barrier properties under the influence of hydrocortisone | Q46615513 | ||
| Developmental expression pattern of Stra6, a retinoic acid-responsive gene encoding a new type of membrane protein | Q48050043 | ||
| Retinoid receptors promote primary neurogenesis in Xenopus. | Q48055937 | ||
| Puromycin-purified rat brain microvascular endothelial cell cultures exhibit improved barrier properties in response to glucocorticoid induction. | Q48599756 | ||
| Electrical resistance of brain microvascular endothelium. | Q48933784 | ||
| Vitamin A-deficient quail embryos have half a hindbrain and other neural defects. | Q49036731 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported | Q19125045 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | blood–brain barrier | Q221694 |
| multicellularity | Q110243984 | ||
| P304 | page(s) | 4160 | |
| P577 | publication date | 2014-02-24 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | A retinoic acid-enhanced, multicellular human blood-brain barrier model derived from stem cell sources | |
| P478 | volume | 4 |
| Q27026457 | 3D in vitro modeling of the central nervous system |
| Q47120880 | 96 perfusable blood vessels to study vascular permeability in vitro |
| Q92685913 | A Simplified, Fully Defined Differentiation Scheme for Producing Blood-Brain Barrier Endothelial Cells from Human iPSCs |
| Q89983564 | A dynamic perfusion based blood-brain barrier model for cytotoxicity testing and drug permeation |
| Q47830673 | A novel human induced pluripotent stem cell blood-brain barrier model: Applicability to study antibody-triggered receptor-mediated transcytosis. |
| Q28543817 | A predictive in vitro model of the impact of drugs with anticholinergic properties on human neuronal and astrocytic systems |
| Q47350712 | A simple cell transport device keeps culture alive and functional during shipping. |
| Q28539764 | A stable and reproducible human blood-brain barrier model derived from hematopoietic stem cells |
| Q92257741 | ABC Transporters at the Blood-Brain Interfaces, Their Study Models, and Drug Delivery Implications in Gliomas |
| Q33560284 | Accelerated differentiation of human induced pluripotent stem cells to blood-brain barrier endothelial cells. |
| Q46115062 | Activation of RARα, RARγ, or RXRα Increases Barrier Tightness in Human Induced Pluripotent Stem Cell-Derived Brain Endothelial Cells |
| Q43062537 | Advances in brain barriers and brain fluid research and news from Fluids and Barriers of the CNS. |
| Q26745911 | Advancing cardiovascular tissue engineering |
| Q66679557 | All Together Now: Modeling the Interaction of Neural With Non-neural Systems Using Organoid Models |
| Q42182270 | An integrative microfluidically supported in vitro model of an endothelial barrier combined with cortical spheroids simulates effects of neuroinflammation in neocortex development. |
| Q42804873 | An isogenic blood-brain barrier model comprising brain endothelial cells, astrocytes, and neurons derived from human induced pluripotent stem cells. |
| Q92457828 | An isogenic neurovascular unit model comprised of human induced pluripotent stem cell-derived brain microvascular endothelial cells, pericytes, astrocytes, and neurons |
| Q38841460 | Analysis of Cancer-Targeting Alkylphosphocholine Analogue Permeability Characteristics Using a Human Induced Pluripotent Stem Cell Blood-Brain Barrier Model. |
| Q50177856 | Analysis of Lymphocyte Extravasation Using an In Vitro Model of the Human Blood-brain Barrier. |
| Q89947938 | Antibody transcytosis across brain endothelial-like cells occurs nonspecifically and independent of FcRn |
| Q59793802 | Benchmarking in vitro tissue-engineered blood-brain barrier models |
| Q90110906 | Biology of the human blood-nerve barrier in health and disease |
| Q30358385 | Biology-inspired microphysiological system approaches to solve the prediction dilemma of substance testing |
| Q47910464 | Blood-brain barrier dysfunction and recovery after ischemic stroke |
| Q35837961 | Blood-brain barrier modeling: challenges and perspectives |
| Q47970111 | Blood-brain barrier models derived from individual patients: a new frontier: An Editorial Highlight on 'An isogenic blood-brain barrier model comprising brain endothelial cells, astrocytes, and neurons derived from human induced pluripotent stem cel |
| Q38267318 | Blood-brain barrier models: in vitro to in vivo translation in preclinical development of CNS-targeting biotherapeutics |
| Q90061953 | Brain Delivery of a Potent Opioid Receptor Agonist, Biphalin during Ischemic Stroke: Role of Organic Anion Transporting Polypeptide (OATP) |
| Q55032220 | Brain vascular heterogeneity: implications for disease pathogenesis and design of in vitro blood-brain barrier models. |
| Q88465572 | Bridging barriers: a comparative look at the blood-brain barrier across organisms |
| Q28822276 | Cerebral hypoxia/ischemia selectively disrupts tight junctions complexes in stem cell-derived human brain microvascular endothelial cells |
| Q48218690 | Characterisation of human induced pluripotent stem cell-derived endothelial cells under shear stress using an easy-to-use microfluidic cell culture system. |
| Q47675024 | Comparative study of expression and activity of glucose transporters between stem cell-derived brain microvascular endothelial cells and hCMEC/D3 cells |
| Q60920173 | Comparison between Polybutylcyanoacrylate Nanoparticles with Either Surface-Adsorbed or Encapsulated Brain-Derived Neurotrophic Factor on the Neural Differentiation of iPSCs |
| Q34577527 | Concise review: tissue-specific microvascular endothelial cells derived from human pluripotent stem cells |
| Q47675953 | Controlling Differentiation of Stem Cells for Developing Personalized Organ-on-Chip Platforms. |
| Q46870120 | Cryopreservation of Brain Endothelial Cells Derived from Human Induced Pluripotent Stem Cells Is Enhanced by Rho-Associated Coiled Coil-Containing Kinase Inhibition |
| Q93179088 | Derivation of Brain Capillary-like Endothelial Cells from Human Pluripotent Stem Cell-Derived Endothelial Progenitor Cells |
| Q48126664 | Development of a direct contact astrocyte-human cerebral microvessel endothelial cells blood-brain barrier coculture model |
| Q33733071 | Differential Effects of Retinoic Acid Concentrations in Regulating Blood-Brain Barrier Properties |
| Q35827703 | Differentiation and characterization of human pluripotent stem cell-derived brain microvascular endothelial cells |
| Q47100977 | Directed differentiation of human pluripotent stem cells to blood-brain barrier endothelial cells |
| Q37110622 | Diverse Functions of Retinoic Acid in Brain Vascular Development. |
| Q89855148 | Drug Development for Central Nervous System Diseases Using In Vitro Blood-brain Barrier Models and Drug Repositioning |
| Q93099667 | Effect of heat stress on blood-brain barrier integrity in iPS cell-derived microvascular endothelial cell models |
| Q38695766 | Effect of shear stress on iPSC-derived human brain microvascular endothelial cells (dhBMECs). |
| Q36419596 | Efficient differentiation of human embryonic stem cells to arterial and venous endothelial cells under feeder- and serum-free conditions. |
| Q89133438 | Endothelial cells are critical regulators of iron transport in a model of the human blood-brain barrier |
| Q90706949 | Engineered nanoparticles for systemic siRNA delivery to malignant brain tumours |
| Q47163222 | Engineering the human blood-brain barrier in vitro |
| Q92962663 | Enhanced xeno-free differentiation of hiPSC-derived astroglia applied in a blood-brain barrier model |
| Q91811166 | Establishment of a Human Blood-Brain Barrier Co-Culture Model Mimicking the Neurovascular Unit Using Induced Pluripotent Stem Cells |
| Q40278164 | Establishment of a Human Blood-Brain Barrier Co-culture Model Mimicking the Neurovascular Unit Using Induced Pluri- and Multipotent Stem Cells. |
| Q35683426 | Exploring the effects of cell seeding density on the differentiation of human pluripotent stem cells to brain microvascular endothelial cells |
| Q58696926 | Fantastic voyage: the journey of intestinal microbiota-derived microvesicles through the body |
| Q49795132 | Functional brain-specific microvessels from iPSC-derived human brain microvascular endothelial cells: the role of matrix composition on monolayer formation. |
| Q28548080 | Generation of Brain Microvascular Endothelial-Like Cells from Human Induced Pluripotent Stem Cells by Co-Culture with C6 Glioma Cells |
| Q90146492 | Gliotoxin penetrates and impairs the integrity of the human blood-brain barrier in vitro |
| Q38779058 | Growth-factor reduced Matrigel source influences stem cell derived brain microvascular endothelial cell barrier properties |
| Q92843677 | HDL from an Alzheimer's disease perspective |
| Q28551318 | Human Brain Microvascular Endothelial Cells Derived from the BC1 iPS Cell Line Exhibit a Blood-Brain Barrier Phenotype |
| Q99589766 | Human iPSC-Derived Blood-Brain Barrier Models: Valuable Tools for Preclinical Drug Discovery and Development? |
| Q51416081 | Human iPSC-Derived Endothelial Cells and Microengineered Organ-Chip Enhance Neuronal Development. |
| Q58552757 | Human iPSC-derived blood-brain barrier microvessels: validation of barrier function and endothelial cell behavior |
| Q64100139 | Human pluripotent stem cell-derived brain pericyte-like cells induce blood-brain barrier properties |
| Q45611249 | Huntington's Disease iPSC-Derived Brain Microvascular Endothelial Cells Reveal WNT-Mediated Angiogenic and Blood-Brain Barrier Deficits |
| Q88199451 | Hyaluronan impairs the barrier integrity of brain microvascular endothelial cells through a CD44-dependent pathway |
| Q35163849 | Hydrocortisone enhances the barrier properties of HBMEC/ciβ, a brain microvascular endothelial cell line, through mesenchymal-to-endothelial transition-like effects |
| Q64900124 | Hypoxia-enhanced Blood-Brain Barrier Chip recapitulates human barrier function and shuttling of drugs and antibodies. |
| Q38758994 | In vitro characterization of pralidoxime transport and acetylcholinesterase reactivation across MDCK cells and stem cell-derived human brain microvascular endothelial cells (BC1-hBMECs). |
| Q89057060 | In vitro models of molecular and nano-particle transport across the blood-brain barrier |
| Q64916610 | Induced Pluripotent Stem Cell-Derived Brain Endothelial Cells as a Cellular Model to Study Neisseria meningitidis Infection. |
| Q64249247 | Induction of Mesoderm and Neural Crest-Derived Pericytes from Human Pluripotent Stem Cells to Study Blood-Brain Barrier Interactions |
| Q38730069 | In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use. |
| Q92587953 | Is there a central role for the cerebral endothelium and the vasculature in the brain response to conditioning stimuli? |
| Q48292903 | Isogenic blood-brain barrier models based on patient-derived stem cells display inter-individual differences in cell maturation and functionality |
| Q48629588 | Microfluidic blood-brain barrier model provides in vivo-like barrier properties for drug permeability screening. |
| Q26747691 | Microfluidic organ-on-chip technology for blood-brain barrier research |
| Q57479119 | Microphysiological 3D model of amyotrophic lateral sclerosis (ALS) from human iPS-derived muscle cells and optogenetic motor neurons |
| Q38666481 | Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells |
| Q45826985 | Modeling Group B Streptococcus and Blood-Brain Barrier Interaction by Using Induced Pluripotent Stem Cell-Derived Brain Endothelial Cells |
| Q49601349 | Modeling Neurovascular Disorders and Therapeutic Outcomes with Human-Induced Pluripotent Stem Cells. |
| Q46205341 | Modeling Psychomotor Retardation using iPSCs from MCT8-Deficient Patients Indicates a Prominent Role for the Blood-Brain Barrier. |
| Q55055706 | Modeling and rescue of defective blood-brain barrier function of induced brain microvascular endothelial cells from childhood cerebral adrenoleukodystrophy patients. |
| Q94064373 | Modeling the blood-brain barrier: Beyond the endothelial cells |
| Q89810596 | Modulation of in vitro Brain Endothelium by Mechanical Trauma: Structural and Functional Restoration by Poloxamer 188 |
| Q38824367 | Morphogens and blood-brain barrier function in health and disease |
| Q30352890 | NIH workshop report on the trans-agency blood-brain interface workshop 2016: exploring key challenges and opportunities associated with the blood, brain and their interface. |
| Q38275050 | Nanoparticles and the blood-brain barrier: advancing from in-vitro models towards therapeutic significance |
| Q38381835 | Neuronal and vascular interactions. |
| Q97418952 | Neuronal regulation of the blood-brain barrier and neurovascular coupling |
| Q38991126 | New experimental models of the blood-brain barrier for CNS drug discovery. |
| Q92980146 | Nutritional supplementation of vitamin A and health-related outcomes in patients with multiple sclerosis: A protocol for a systematic review and meta-analysis of randomized clinical trials |
| Q93054814 | Organ-On-A-Chip in vitro Models of the Brain and the Blood-Brain Barrier and Their Value to Study the Microbiota-Gut-Brain Axis in Neurodegeneration |
| Q49569055 | Organoid and Organ-On-A-Chip Systems: New Paradigms for Modeling Neurological and Gastrointestinal Disease. |
| Q66679638 | Past and Current Perspectives in Modeling Bacteria and Blood-Brain Barrier Interactions |
| Q55240298 | Pharmaceutical iron formulations do not cross a model of the human blood-brain barrier. |
| Q93068407 | Phase 0 Clinical Trial Strategies for the Neurosurgical Oncologist |
| Q91130089 | Proof-of-Concept Study of Drug Brain Permeability Between in Vivo Human Brain and an in Vitro iPSCs-Human Blood-Brain Barrier Model |
| Q93160159 | Recent advances in human iPSC-derived models of the blood-brain barrier |
| Q36372454 | Retinoic Acid Induced-Autophagic Flux Inhibits ER-Stress Dependent Apoptosis and Prevents Disruption of Blood-Spinal Cord Barrier after Spinal Cord Injury |
| Q40306099 | Retinoic Acid Prevents Disruption of Blood-Spinal Cord Barrier by Inducing Autophagic Flux After Spinal Cord Injury |
| Q91886011 | Retinoic acid signaling in vascular development |
| Q64900504 | Role of iPSC-derived pericytes on barrier function of iPSC-derived brain microvascular endothelial cells in 2D and 3D. |
| Q41078810 | Serum retinol levels are associated with brain volume loss in patients with multiple sclerosis |
| Q93160323 | Serum-derived factors of breast cancer patients with brain metastases alter permeability of a human blood-brain barrier model |
| Q38597068 | Stem cell-derived vasculature: A potent and multidimensional technology for basic research, disease modeling, and tissue engineering. |
| Q91735295 | Strategies for derivation of endothelial lineages from human stem cells |
| Q92755051 | Streptococcus agalactiae disrupts P-glycoprotein function in brain endothelial cells |
| Q64899660 | Studying Heterotypic Cell⁻Cell Interactions in the Human Brain Using Pluripotent Stem Cell Models for Neurodegeneration. |
| Q92378165 | Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models |
| Q28086851 | TEER measurement techniques for in vitro barrier model systems |
| Q95840773 | The Isolated Brain Microvessel: A Versatile Experimental Model of the Blood-Brain Barrier |
| Q41243197 | The Microvascular Gap Junction Channel: A Route to Deliver MicroRNAs for Neurological Disease Treatment |
| Q28087222 | The molecular constituents of the blood-brain barrier |
| Q91860762 | The role of mutations associated with familial neurodegenerative disorders on blood-brain barrier function in an iPSC model |
| Q41440571 | Therapeutic strategies for spinal muscular atrophy: SMN and beyond. |
| Q47805415 | Tissue Engineering the Vascular Tree |
| Q41844621 | Tissue-engineered blood vessels as promising tools for testing drug toxicity. |
| Q92497246 | Ultrathin Silicon Membranes for in Situ Optical Analysis of Nanoparticle Translocation across a Human Blood-Brain Barrier Model |
| Q38801331 | Validation of an immortalized human (hBMEC) in vitro blood-brain barrier model |
| Q64249273 | iPSC-Derived Brain Endothelium Exhibits Stable, Long-Term Barrier Function in Perfused Hydrogel Scaffolds |
| Q47247599 | iPSCs-based generation of vascular cells: reprogramming approaches and applications. |
| Q35602819 | pH responsive granulocyte colony-stimulating factor variants with implications for treating Alzheimer's disease and other central nervous system disorders |
| Q48095983 | β-Catenin Is Required for Endothelial Cyp1b1 Regulation Influencing Metabolic Barrier Function |
Search more.